Journals / Molecular Imaging and Radionuclide Therapy / 2012 / Cilt: 21 - Sayı: 1

Pediatrik hastalarda Tc-99m HMPAO işaretli Lökosit sintigrafisi

Tc-99m labeled HMPAO white blood cell scintigraphy in pediatric patients

Pages
13–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results showed that WBC scintigraphy might be reliably used for diagnosis of suspected bone infection and acute appendicitis, fever of unknown origin, and acute appendicitis, in pediatric patient population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: 99mTc labeled hexamethylpropylene amine oxime (HMPAO) white blood cell (WBC) scintigraphy is a frequently used option for acute infection, particularly in pediatric patients.
📊
Key Findings & Data:The aim of this retrospective study was to evaluate the value of 99mTc-HMPAO labeled WBC scintigraphy in pediatric patients.
💡
Conclusion & Impact:Our results showed that WBC scintigraphy might be reliably used for diagnosis of suspected bone infection and acute appendicitis, fever of unknown origin, and acute appendicitis, in pediatric patient population.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: 99mTc labeled hexamethylpropylene amine oxime (HMPAO) white blood cell (WBC) scintigraphy is a frequently used option for acute infection, particularly in pediatric patients. This scintigraphy is applied to detect sites of infection/inflammation in patients with fever of unknown origin, to find and follow up osteomyelitis, and to detect suspicion of acute appendicitis. The aim of this retrospective study was to evaluate the value of 99mTc-HMPAO labeled WBC scintigraphy in pediatric patients. Material and Methods: The study was conducted between January 2006 and December 2008 and included 13 patients (5 boys, 8 girls; mean age 6.9±6.2 years). Those patients who had suspicion of bone infection (n=7), fever of unknown origin (n=3), and suspicion of acute appendicitis (n=3) were evaluated retrospectively. 99mTc-HMPAO labeled WBC scintigraphy imaging was performed to all patients. Diagnosis was done according to operation and pathological results or clinical follow-up. Results: 99mTc-HMPAO labeled WBC scintigraphy has been found to be true positive in 6 cases, true negative in 6 cases, and false negative in one patient who had fewer unknown origin. The false negative case has been found to have encephalitis with MRI. Conclusion: Leukocyte scintigraphy has been described as a useful diagnostic tool in the diagnosis of suspicion of bone infection, fever of unknown origin and suspicion of acute appendicitis. 99mTc-HMPAO labeled WBC scintigraphy is a rapid and very accurate method for detecting those pathologies. Our results showed that WBC scintigraphy might be reliably used for diagnosis of suspected bone infection and acute appendicitis, fever of unknown origin, and acute appendicitis, in pediatric patient population.

Özet

Amaç: 99mTc hexamethylpropylene amine oxime (HMPAO) ile işaretli lökosit sintigrafisi özellikle çocuklarda akut enfeksiyon için sıklıkla kullanılır. Lökosit sintigrafisi nedeni bilinmeyen ateş olgularında infeksiyon/inflamasyonu tanımlamada, osteomyelit tanısı ve takibinde ve akut apendisit şüphesinde uygulanır. Bu retrospektif çalışmanın amacı pediatrik hastalarda 99mTc HMPAO ile işaretli lökosit sintigrafisini değerlendirmekti. Gereç ve Yöntemler: Çalışma Ocak 2006 ve Aralık 2008 tarihleri arasında yürütüldü ve 13 hasta (5 erkek, 8 kız; ortalama yaş 6,9±6,2 yaş) dahil edildi. Kemik enfeksiyonu şüphesi (n=7), nedeni bilinmeyen ateş (n=3), ve akut apendisit şüphesi (n=3) olan bu hastalar retrospektif olarak değerlendirildi. 99mTc-HMPAO işaretli lökosit sintigrafisi tüm hastalara yapıldı. Tanı operasyon ve patolojik sonuç veya klinik takibe göre konuldu. Bulgular: 99mTc-HMPAO işaretli lökosit sintigrafisi 6 olguda gerçek pozitif, 6 vakada gerçek negatif ve nedeni bilinmeyen ateşi olan 1 olguda da yalancı negatif olarak bulundu. Yalancı negatif vakanın tanısı MRI ile konuldu. Sonuç: Lökosit sintigrafisi kemik enfeksiyonu şüphesinde, nedeni bilinmeyen ateşte ve akut apendisit şüphesinde yararlı tanısal tetkik olarak tanımlanmıştır. 99mTc-HMPAO işaretli lökosit sintigrafisi bu patolojilerin tanısı için hızlı ve çok doğru yöntemdir. Bizim sonuçlarımız pediatrik hasta populasyonunda işaretli lökosit sintigrafisinin enfeksiyon şüphesinde, nedeni bilinmeyen ateşte ve akut apendisit şüphesinde güvenilir olabileceğini gösterdi.

🔖

Cite This Article

AYDIN, F., CENGİZ, A. K., GÜNGÖR, F. (2012). Pediatrik hastalarda Tc-99m HMPAO işaretli Lökosit sintigrafisi. Molecular Imaging and Radionuclide Therapy, Cilt: 21 - Sayı: 1, 13–18. https://ajindex.com/articles/295226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Q J Nucl Med Mol Imaging 2006;50:147-152. 2.Djekidel M, Brown RKJ, Piert M. Benefits of hybrid SPECT/CT for 111In-Oxine- and Tc-99m-Hexamethylpropylene Amine Oxime- labeled leukocyte imaging. Clin Nucl Med 2011;36:50-56. 3.Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging 2009;53:105-123. 4.Bleeker-Rovers CP van der Meer JWM, Oyen WJG. Fever of unknown origin. Semin Nucl Med 2009;39:81-87. 5.Segal AW, Arnot RN, Thakur ML, Lavender JP Indium-111-labeled leucocytes for localisation of abscesses. Lancet 1976;13:1056-1058. 6.Ballinger JR, Gnanasegaran G. Radiolabeled leukocytes for imaging inflammation: how radiochemistry affects clinical use. Q J Nucl Med Mol Imaging 2005;49:308-318. 7.Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, Kelly JD, Neirinckx RD, Lavender JP Clinical experience with 99mTc-hexamethylpropyleneamine oxime for labeling leucocytes and imaging inflammation. Lancet 1986;25:946-949. 8.Scholmerich J, Schmidt E, Schumichen C, Billmann P Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m- hexamethyl propylene amine oxime as leukocyte label. Gastroenterology 1988;95:1287-1293. 9.Li DJ, Middleton SJ, Wright EP 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease. Nucl Med Commun 1992;13:867-870. 10.Hughes DK. Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc- HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. J Nucl Med Technol 2003;31:196-201. 11.McAfee JG. What is the best method for imaging focal infections? J Nucl Med 1990;31:413-416. 12.Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994;24:110-127. 13.Roca M, Martín-Comín J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A, Peters M, Prats E, Rodrigues M, Sampson C, Signore A, Sinzinger H, Thakur M. A consensus protocol for white blood cells labeling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998;25:797-799. 14.Chianelli M, Mather SJ, Martin-Comin J, Signore A. Radiopharmaceuticals for the study of inflammatory processes: a review. Nucl Med Commun 1997;18:437-455. 15.Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997;27:334-345.